Increased expression of hypoxia-inducible factor-1 alpha and its impact on transcriptional changes and prognosis in malignant tumours of the ocular adnexa
暂无分享,去创建一个
Martin Boeker | Thomas Reinhard | Ralf Horres | Patrick Lehnert | Daniel Böhringer | R. Horres | M. Boeker | D. Böhringer | K. Hoffmeier | T. Reinhard | C. Lange | Claudia Auw-Haedrich | G. Schlunck | Günther Schlunck | Clemens Alexander Klaus Lange | Stefaniya Konstantinova Boneva | Peipei Zhang | Franziska Ludwig | Klaus Hoffmeier | S. Boneva | C. Auw-Haedrich | Patrick Lehnert | Peipei Zhang | F. Ludwig
[1] E. Vêncio,et al. Expression of hypoxia-induced factor-1 alpha in early-stage and in metastatic oral squamous cell carcinoma , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[2] Kun Xu,et al. Retraction Note to: CXCR4 Signaling Induced Epithelial-Mesenchymal Transition by PI3K/AKT and ERK Pathways in Glioblastoma , 2015, Molecular Neurobiology.
[3] H. Grossniklaus,et al. Conjunctival Lymphoma--An International Multicenter Retrospective Study. , 2016, JAMA ophthalmology.
[4] H. Youssef,et al. Correlation of hypoxia-inducible factor-1 alpha (HIF-1α) and vascular endothelial growth factor (VEGF) expressions with clinico-pathological features of oral squamous cell carcinoma (OSCC) , 2015 .
[5] G. Kayser,et al. Prognostic Value of Malic Enzyme and ATP-Citrate Lyase in Non-Small Cell Lung Cancer of the Young and the Elderly , 2015, PloS one.
[6] R. Horres,et al. De novo transcriptome analysis and highly sensitive digital gene expression profiling of Calliphora vicina (Diptera: Calliphoridae) pupae using MACE (Massive Analysis of cDNA Ends). , 2015, Forensic science international. Genetics.
[7] Kun Xu,et al. RETRACTED ARTICLE: CXCR4 Signaling Induced Epithelial-Mesenchymal Transition by PI3K/AKT and ERK Pathways in Glioblastoma , 2014, Molecular Neurobiology.
[8] Max Costa,et al. Molecular Responses to Hypoxia-Inducible Factor 1α and Beyond , 2014, Molecular Pharmacology.
[9] S. Steinberg,et al. Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors , 2014, Cancer Chemotherapy and Pharmacology.
[10] Ban-zhou Pan,et al. Clinical significance of angiopoietin-like protein 4 expression in tissue and serum of esophageal squamous cell carcinoma patients , 2013, Medical Oncology.
[11] J. Schwartzkopff,et al. Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome. , 2012, Ophthalmology.
[12] E. L. West,et al. Von Hippel-Lindau protein in the RPE is essential for normal ocular growth and vascular development , 2012, Development.
[13] G. Semenza,et al. Hypoxia-Inducible Factors in Physiology and Medicine , 2012, Cell.
[14] J. L. Ding,et al. ANGPTL4 modulates vascular junction integrity by integrin signaling and disruption of intercellular VE-cadherin and claudin-5 clusters. , 2011, Blood.
[15] W. Wilson,et al. Targeting hypoxia in cancer therapy , 2011, Nature Reviews Cancer.
[16] J. L. Ding,et al. Angiopoietin-like 4 protein elevates the prosurvival intracellular O2(-):H2O2 ratio and confers anoikis resistance to tumors. , 2011, Cancer cell.
[17] R. Ali,et al. HIF-1alpha and HIF-2alpha Are Differentially Activated in Distinct Cell Populations in Retinal Ischaemia , 2010, PloS one.
[18] T. Acker,et al. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors. , 2010, Cancer research.
[19] Xuegong Zhang,et al. DEGseq: an R package for identifying differentially expressed genes from RNA-seq data , 2010, Bioinform..
[20] Markus Rudin,et al. Longitudinal and multimodal in vivo imaging of tumor hypoxia and its downstream molecular events , 2009, Proceedings of the National Academy of Sciences.
[21] Samy Lamouille,et al. TGF-β-induced epithelial to mesenchymal transition , 2009, Cell Research.
[22] J. Erler,et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. , 2009, Cancer cell.
[23] M. Celeste Simon,et al. The impact of O2 availability on human cancer , 2008, Nature Reviews Cancer.
[24] G. Vassaux,et al. Uveal vs. cutaneous melanoma. Origins and causes of the differences , 2008, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
[25] M. Carini,et al. Re: Anders Lidgren, Ylva Hedberg, Kjell Grankvist, Torgny Rasmuson, Anders Bergh and Börje Ljungberg. Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray. Eur Urol 2006;50:1272-7. , 2007, European urology.
[26] K. Grankvist,et al. Hypoxia-Inducible Factor 1α Expression in Renal Cell Carcinoma Analyzed by Tissue Microarray , 2006 .
[27] P. Maxwell. The HIF pathway in cancer. , 2005, Seminars in cell & developmental biology.
[28] P. V. van Diest,et al. HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor , 2005, BMC Cancer.
[29] C. Dalgard,et al. Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma. , 2005, Neoplasia.
[30] A. Harris,et al. Differential prognostic impact of hypoxia induced and diffuse HIF-1α expression in invasive breast cancer , 2005, Journal of Clinical Pathology.
[31] M. Tachibana,et al. Prognostic Impact of Hypoxia-Inducible Factors 1α and 2α in Colorectal Cancer Patients , 2004, Clinical Cancer Research.
[32] A. Harris,et al. Hypoxia‐inducible factor‐1α in non small cell lung cancer: Relation to growth factor, protease and apoptosis pathways , 2004, International journal of cancer.
[33] P. Jaakkola,et al. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. , 2004, The Biochemical journal.
[34] S. Mccormick,et al. Conjunctival melanoma: is it increasing in the United States? , 2003, American journal of ophthalmology.
[35] A. Tarkkanen,et al. Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. , 2002, Investigative ophthalmology & visual science.
[36] A. Harris,et al. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages , 2000 .
[37] A. Harris,et al. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. , 2000, The American journal of pathology.
[38] J. Goedert,et al. Epidemiology of squamous cell conjunctival cancer. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.